NCT06210165View on ClinicalTrials.gov

Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Atelectasis, PostoperativePulmonary Function; Newborn, Abnormal
Interventions
DRUG

Sugammadex

IV Sugammadex 4mg/kg stat once TOF ratio 0.7-0.9 after completing surgery

DRUG

Neostigmine and atropine

IV neostigmine 40mcg/kg in combination with IV atropine 10mcg/kg stat once TOF ratio 0.7-0.9 after completing surgery

Trial Locations (1)

16150

RECRUITING

University of Science Malaysia Hospital, Kubang Kerian

All Listed Sponsors
lead

Rhendra Hardy Mohamad Zaini

OTHER